from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2285/-

LFCtreatmentdescriptionclass of inhibitor

-0.380

Amikacinug/mL Amikacintranslation

-0.678

Cap5-10ug/mL Capreomycintranslation

-0.808

Rox10-50 ug/mL Roxithromycintranslation

-0.042

SM2-5 ug/mL Streptomycintranslation

0.608

Tet5-10 ug/mL Tetracyclinetranslation

1.701

Rif0.2-5ug/mL Rifampicintranscription

-0.124

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.490

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.435

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.239

CPZ10-50 ug/mL Chlorpromazinerespiration

1.060

Clofazimine10-13 ug/mL Clofaziminerespiration

0.692

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.310

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.276

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.007

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.573

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.309

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.844

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.267

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.426

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.129

KCN5-20 ug/mL Potassium cyaniderespiration

0.206

NaN30.2-2 mM Sodium aziderespiration

-0.393

Nigericin50 uM Nigericinrespiration

0.149

TRC10-150 ug/mL Triclosanrespiration

0.668

TRZ10-25 ug/mL Thioridazinerespiration

-2.494

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.042

menadione6-10 ug/mL Menadionerespiration

0.151

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.398

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.328

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.834

NRP_1Non-replicating persistence stage 1dosRassociated

-0.360

Amp0.2mg/mL AmpicillincellWall

-0.601

Cephalexin20-100 ug/mL CephalexincellWall

-0.084

Cerulenin0.32-5 ug/mL CerulenincellWall

0.665

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.447

EMB10-20 ug/mL EthambutolcellWall

-0.219

Eta12-40 ug/mL EthionamidecellWall

-0.458

INH0.2-0.4 ug/mL IsoniazidcellWall

0.039

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.078

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.433

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.270

BZA0.12 mg/mL BenzamidearomaticAmides

-0.153

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.270

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.560

H2O24 mM hydrogen peroxideDNAdamaging

-0.283

Levo10 ug/mL LevofloxacinDNAdamaging

0.071

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.933

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.430

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.218

UVUV-irradiationDNAdamaging

-0.292

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.440

Antimycin12.5-50 ug/mL Antimycin A?

-0.217

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.351

PA_110-50 ug/mL Antitubercular compound PA-1?

0.552

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.114

PA8240.2-2 ug/mL PA-824?

-1.030

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.177

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.865

Verapamil50 uM Verapamil?

0.529

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.229

methoxatin10-20 ug/mL Methoxatin?